NIH-funded research Fellowship grant

Understanding how reovirus RNA is packaged into viral particles

Official title: Elucidating RNA determinants for reovirus packaging

Funded at Vanderbilt University · NIH-10997529 · Data updated 2026-11-12

This study is looking at how a virus called reovirus puts its genetic material together, which could help scientists create better vaccines and cancer treatments that use this virus to fight disease.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionVanderbilt University
NIH-funded
Lab location1 site (Nashville, UNITED STATES)
Project startAugust 1, 2024
Project endJuly 31, 2025
Funding year2024
Award (this year)$34,370
NIH project number1F31AI186483-01
Project IDNIH-10997529 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research would include individuals with cancers that may be treated with oncolytic viruses.

Less likely to help

Patients with non-cancerous conditions or those not eligible for oncolytic virus therapies may not receive benefits from this research.

What this research studies

This research investigates the mechanisms by which reovirus, a type of virus with a complex RNA structure, packages its genetic material into viral particles. By focusing on the RNA segments that are crucial for this packaging process, the research aims to identify specific signals and structures that facilitate the correct assembly of the virus. This could lead to advancements in genetically modifying reovirus for use in vaccines and cancer therapies. Patients may benefit from improved treatments that harness the oncolytic properties of reovirus.

Why it matters

Potential benefit: If successful, this research could lead to more effective cancer treatments using reovirus as a therapeutic agent.

How similar studies have gone: Previous research has shown promise in using similar viral packaging mechanisms for therapeutic applications, indicating potential for success in this area.

Where this research is happening

  • Vanderbilt University
    Nashville, United States
    Active

Researchers

  • Principal investigator: Flores, Alejandra — Vanderbilt University
  • Study coordinator: Flores, Alejandra

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.